Overweight and obesity vs. Metabolic complications In a group of per-sons with intellectual disabilities. Preliminary study
Keywords:
intellectual disabilities, disturbances of carbohydrate metabolism and lipid, metabolic syndromeAbstract
Introduction: Obesity is a major health problem within the population of those with intellectual disabilities. It carries with it a number of negative health consequences that lead to, inter alia, overpressure of the blood, carbohydrate-lipid metabolism disturbances, diabetes type II, cardiovascular disease and stroke. Many forms of obesity in people with mental disabilities are of a genetic background, however, of great importance in its formation is life-style choices and health care system practices.
Material and methods: This study included 24 people at 24 to 52 years of age, in whom a diagnosis had been made prior to their attaining 16 years of age, of mild and moderate mental impairment. From these persons, we took venous blood samples (after fasting) in order to obtain data on total cholesterol (TC), HDL cholesterol (HDL), LDL cholesterol (LDL), triglycerides (TG), and glucose (GLUC) levels.
Results: Overweight and obesity were diagnosed in 25% of all women and in 25% of all men, whereas obesity was seen in 16% of all women and 23% all men, respectively. A particular problem appeared to be abdominal obesity. This was evident in 41,7% of all surveyed (58,3% of all women and 50% of all men). In addition, hypercholesterolemia was common, and was diagnosed in 75% of all women and 16.7% of all men. This represented 46% of the total surveyed.
Conclusions: Our study revealed that environmental factors conducive to mental stimulation, above all, the possibility of em-ployment, foster motor activity. This positively affects the correct metabolic transformation in people with intellectual disabilities.
References
1. De Hert M, Correll ChU, Bobes J, Cetkovich-Bakmas M, Cohen D, Asai I, Detraux J et al. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care, World Psychiatry 2011, 52-77.
2. Department of Health, Government of South Australia 2006, http://www.health.sa.gov.au.
3. Bray GA. Prevalence of Obesity and the Metabolic Syndrome. In: Mokdad AH, Ford ES, editors. Overweight and the metabolic syndrome, from bench to beside, 2006 Springe, p.37-53.
4. World Health Organization Technical report series 894: Obesity: preventing and managing the global epidemic. Geneva: World Health Organization 2000.
5. World Health Organization (2011) Global Database on Body Mass Index. An interactive surveillance tool for monitoring nutrition transition. http://apps.who.int/bmi.
6. Alberti G, Zimmet PZ, Shaw J, Grundy SM. International Diabetes Federation 2006: The IDF consensus worldwide definition of the metabolic syndrome. http://www.idf.org/webdata/docs /IDF_Meta_def_final.pdf.
7. Rimmer JH, Yamaki K. Obesity and intellectual disability, Mental Retardation and Development Disabilities, 12: 22-27, 2006.
8. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)., JAMA. 2001 May 16;285(19):2486-97.
9. Stancliffe RJ, Lakin KC, Larson S, Engler J, Bershadsky J, Taub S, et al. Overweight and obesity among adults with intellectual disabilities who use intellectual disability/developmental disability services in 20 U.S. States. Am J Intellect Dev Disabil 2011, 116:401-18.
10. Emerson E. Underweight, obesity and exercise among adults with intellectual disabilities in supported accommodation in Northern England. Journal of Intellectual Disability Research 2005, 49: 2, 134-143.
11. Spanos D, Melville CM, Hankey CR. Weight management interventions in adults with intellectual disabilities and obesity: a systematic review of the evidence. Nutrition Journal 2013, 12:132, http://www.nutritionj.com /content/12/1/132.
12. Yamaki K. Body weight status among adults with intellectual disability in the community. Mental Retardation 2005; 43: 1, 1-10.
13. Hoshino S, Yamamoto K, Miyaji S, Sakai Y, Yamamoto H, Yukawa MI et al, Metabolic syndrome in Japanese patients with mental retardation. Medical Case Studies Vol. 2(4), pp. 32-38, June 2011.
14. Rzewuska M. Zaburzenia metaboliczne związane ze stosowaniem LPP u chorych na schizofrenię, Psychiatria Polska, 2007, tom XLI, numer 4, 457–472.
15. Joukamaa M, Heliovaara M, Knekt P, Raitasalo AAR. Mental disorders and cause — specific mortality. Br. J. Psychiatry 2001; 179: 498–502.
16. Meyer JM, Nasrallah HA, McEvoy JP, Goff DC, Davis SM, Chakos M, et al. The Clinical antipsychotic trials of Intervention Effectiveness (CATIE) Schizophrenia Trial: clinical comparison of subgroups with and without the metabolic syndrome. Schizophr Res. 2005 Dec 1;80(1):9-18. Epub 2005 Aug 24.
17. Pużyński S, Wciórka J. Klasyfikacja zaburzeń psychicznych i zaburzeń zachowania wg ICD-10. Opisy kliniczne i wskazówki diagnostyczne, Kraków 2000, wyd.2.
18. Waist circumference and waist-hip ratio. Report of WHO expert consultation, Geneva, 8-11, December 2008.
19. Pająk A, Wiercińska E, Polakowska M, Kozakiewicz K, Kaczmarczyk-Chałas K, Tykarski A, et al. Rozpowszechnienie dyslipidemii u mężczyzn i kobiet w wieku 20–74 lat w Polsce. Wyniki programu WOBASZ, Kardiologia Polska 2005; 63: 6 (supl. 4).
20. Cybulska B, Szostak WB, Kłosiewicz-Latoszek L. Zapobieganie c orobom krążenia. In: Szczeklik A, editor. Interna Szczeklika - Podręcznik chorób wewnętrznych , Medycyna Praktyczna 2013, p.149-165.
21. Wyrzykowski B, Zdrojewski T, Sygnowska E, Biela U, Drygas W, Tykarski A, et al. Epidemiologia zespołu metabolicznego w Polsce. Wyniki programu WOBASZ. Kardiol. Pol., 2005; 63 (supl. 4): S1-S4.
22. Zdrojewski T, Bandosz P, Szpakowski P, Konarski R, Manikowski A, Wołkiewicz E, et al. Rozpowszechnienie głównych czynników ryzyka chorób układu sercowo-naczyniowego w Polsce. Wyniki badania NATPOL PLUS. Kardiol. Pol., 2004, 61 (Supl. IV): IV1-IV26.
23. Chrostowska M, Szyndler A, Polonis K, Tykarski A, Narkiewicz K. Rozpowszechnienie otyłości brzusznej u chorych z nadciśnieniem tętniczym w Polsce — konsekwencja zmiany kryteriów diagnostycznych w zaleceniach Polskiego Towarzystwa Nadciśnienia Tętniczego z 2011 roku, Via Medica, 2011, tom 15, nr 3.
24. Janszky I, Vatten L, Romundstad P, Laugsand LE, Bjorngard JH, Mańczuk M, Zatoński W., Metabolic syndrome in Poland – the PONS Study. Annals of Agricultural and Environmental Medicine 2011, Vol 18, No 2, 270-272.
25. De Winter CF, Magilsen KW, van Alfen JC, Willemsen SP, Evenhuis HM. Metabolic syndrome in 25% of older people with intellectual disability. Fam Pract. 2011 Apr;28(2):141-4.
